Mood stabilizer combinations for bipolar disorder.
Lovell
R W
RW
D000085:Acetates / Q000009:adverse effects; D000293:Adolescent; D000367:Age Factors; D000588:Amines; D018692:Antimanic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy*; D002648:Child; D003509:Cyclohexanecarboxylic Acids; D003875:Drug Eruptions / Q000209:etiology*; D000077206:Gabapentin; D006801:Humans; D000077213:Lamotrigine; D008094:Lithium / Q000009:adverse effects; D014227:Triazines / Q000009:adverse effects* / Q000627:therapeutic use; D014635:Valproic Acid / Q000009:adverse effects; D005680:gamma-Aminobutyric Acid
D000085:Acetates; D000588:Amines; D018692:Antimanic Agents; D003509:Cyclohexanecarboxylic Acids; D014227:Triazines; D005680:gamma-Aminobutyric Acid; D014635:Valproic Acid; D000077206:Gabapentin; D008094:Lithium; D000077213:Lamotrigine